DA
DSC Advisors Portfolio holdings
AUM
$11M
This Quarter Return
+6.31%
1 Year Return
+5.74%
3 Year Return
-3.74%
5 Year Return
+31.24%
10 Year Return
+87.02%
AUM
$63.6M
AUM Growth
+$63.6M
(+21%)
Cap. Flow
+$7.49M
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
94.6%
Holding
31
New
10
Increased
8
Reduced
5
Closed
4
Top Buys
| 1 |
Abbott
ABT
|
$4.52M |
| 2 |
CVS Health
CVS
|
$1.59M |
| 3 |
eHealth
EHTH
|
$1.51M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$979K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$650K |
Top Sells
Sector Composition
| 1 | Healthcare | 56.66% |
| 2 | Industrials | 24.39% |
| 3 | Communication Services | 10.31% |
| 4 | Financials | 6.09% |
| 5 | Technology | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
1
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15.5M | 23.27% | 841,000 -149,000 | -15% | -$2.75M |
|
|
2
CVS Health
CVS
$92.8B
| $10.6M | 15.89% | 153,237 +22,957 | +18% | +$1.59M |
|
3
Zimmer Biomet
ZBH
$21B
| $9.1M | 13.65% | 62,534 +5 | +0% | +$728 |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.67M | 13% | 100,000 +7,500 | +8% | +$650K |
|
5
Alphabet (Google) Class C
GOOG
$2.58T
| $5.56M | 8.34% | 46,000 | – | – |
|
|
6
Abbott
ABT
$231B
| $4.52M | 6.77% | +41,415 | New | +$4.52M |
|
|
7
eHealth
EHTH
$118M
| $3.06M | 4.58% | 380,000 +187,500 | +97% | +$1.51M |
|
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $2.33M | 3.5% | 310,000 +130,000 | +72% | +$979K |
|
9
VYNE Therapeutics
VYNE
$8.16M
| $467K | 0.7% | 115,000 | – | – |
|
10
Microsoft
MSFT
$3.77T
| $365K | 0.55% | 1,073 -177 | -14% | -$60.3K |
|
|
11
Alphabet (Google) Class A
GOOGL
$2.57T
| $343K | 0.51% | 2,865 -600 | -17% | -$71.8K |
|
12
Meta Platforms (Facebook)
META
$1.86T
| $342K | 0.51% | 1,192 -153 | -11% | -$43.9K |
|
13
Visa
V
$683B
| $306K | 0.46% | 1,290 +245 | +23% | +$58.2K |
|
14
Mastercard
MA
$538B
| $299K | 0.45% | 759 +137 | +22% | +$53.9K |
|
15
Adobe
ADBE
$151B
| $261K | 0.39% | +534 | New | +$261K |
|
16
Accenture
ACN
$162B
| $251K | 0.38% | +813 | New | +$251K |
|
17
Zevra Therapeutics
ZVRA
$509M
| $250K | 0.38% | +49,100 | New | +$250K |
|
18
Salesforce
CRM
$245B
| $250K | 0.38% | 1,184 +130 | +12% | +$27.5K |
|
19
Apple
AAPL
$3.45T
| $231K | 0.35% | 1,190 -218 | -15% | -$42.3K |
|
20
Oracle
ORCL
$635B
| $229K | 0.34% | +1,921 | New | +$229K |
|
21
Netflix
NFLX
$513B
| $229K | 0.34% | +519 | New | +$229K |
|
22
Berkshire Hathaway Class B
BRK.B
$1.09T
| $214K | 0.32% | +628 | New | +$214K |
|
23
Enhabit
EHAB
$399M
| $115K | 0.17% | +10,000 | New | +$115K |
|
24
Vivid Seats
SEAT
$115M
| $79.2K | 0.12% | +10,000 | New | +$79.2K |
|
|
COMS
25
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
| $38.5K | 0.06% | +22,500 | New | +$38.5K |
|